Article Information
History
- May 30, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Abena Takyi1,2,3,4,¶,
- Verena I. Carrara1,2,3,5,¶,
- Prabin Dahal1,2,3,
- Marianna Przybylska6,
- Eli Harriss7,
- Genevieve Insaidoo8,
- Karen I. Barnes2,3,9,
- Philippe J Guerin1,2,3,* and
- Kasia Stepniewska1,2,3,*
- 1Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
- 2Infectious Diseases Data Observatory (IDDO), Oxford, United Kingdom
- 3WorldWide Antimalarial Resistance Network (WWARN), Oxford, United Kingdom
- 4Department of Child Health, Korle Bu Teaching Hospital, Accra, Ghana
- 5Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- 6Royal Infirmary Edinburgh, NHS Lothian, Edinburgh, United Kingdom
- 7The Knowledge Centre, Bodleian Health Care Libraries, University of Oxford, Oxford, OX3 7DQ, UK
- 8Holy family Hospital, Nkawkaw, Eastern Region, Ghana
- 9Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa
- ↵*Corresponding authors:
Kasia Stepniewska kasia.stepniewska{at}wwarn.org, Philippe J. Guerin philippe.guerin{at}wwarn.org
↵¶ These authors contributed equally to this work.
Posted May 30, 2023.
Characterisation of populations at risk of sub-optimal dosing of artemisinin-based combination therapy in Africa
